Teresa M. Rocha

Porto, 4200319, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Journal: International journal of molecular sciences

Published: March 16, 2026

Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.

Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.

Journal: Archiv der Pharmazie

Published: March 11, 2026

Tocilizumab as a treatment option in Sjögren disease with associated lymphocytic interstitial pneumonia.

Tocilizumab as a treatment option in Sjögren disease with associated lymphocytic interstitial pneumonia.

Journal: Clinical rheumatology

Published: July 24, 2025

ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases.

ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 24, 2024

Correction to: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

Correction to: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

Journal: Clinical rheumatology

Published: January 30, 2024

What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

Journal: Clinical rheumatology

Published: September 26, 2023

Systemic sclerosis and sarcoidosis: an exceptional coexistence.

Systemic sclerosis and sarcoidosis: an exceptional coexistence.

Journal: ARP rheumatology

Published: August 04, 2022

Pseudotumoral calcinosis of the spine in systemic sclerosis - an atypical location.

Pseudotumoral calcinosis of the spine in systemic sclerosis - an atypical location.

Journal: ARP rheumatology

Published: July 22, 2022

Remission and low disease activity matrix tools: results in real-world rheumatoid arthritis patients under anti-TNF therapy.

Remission and low disease activity matrix tools: results in real-world rheumatoid arthritis patients under anti-TNF therapy.

Journal: Acta reumatologica portuguesa

Published: January 09, 2021

A new approach for interpretability and reliability in clinical risk prediction: Acute coronary syndrome scenario.

A new approach for interpretability and reliability in clinical risk prediction: Acute coronary syndrome scenario.

Journal: Artificial intelligence in medicine

Published: July 20, 2020

Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register.

Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register.

Journal: The Journal of rheumatology

Published: July 15, 2019

The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update.

The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update.

Journal: Acta reumatologica portuguesa

Published: September 13, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026